Main Article Content

Abstract


ABSTRACT
With the COVID-19 pandemic, vaccination appeared to be the only way to overcome the virus. Different pharmaceutical firms raced to find a vaccine. At the same time, there are worries about possible reactions to vaccines. A 30-years old male patient consulted on November 09, 2021 for the appearance of the tender skin rash on the right flank 10 days after receiving the COVID-19 Johnson & Johnson vaccine. On dermatological examination, a confluence of papules and vesicles laying down on erythematous base was observed over the right dorsolumbar area following a dermatomal distribution. Based on clinical finding, and biological examinations returned normal, the diagnosis of right dorsolumbar herpes zoster triggered by anti-COVID-19 vaccination was made. Our case illustrates reactivation of herpes zoster in a young person without any comorbidity after COVID-19 vaccination. If the causal link between anti COVID-19 vaccination and reactivation of VZV was until suspected because of the presence of risk factors in much of the published cases, ours has just been confirmed. This allows us to retain anti-COVID vaccination as trigger factor of herpes zoster.
RÉSUMÉ
Avec la pandémie à COVID-19, la vaccination a semblée être le seul moyen de vaincre le virus; d’où la course des firmes pharmaceutiques afin de trouver un vaccin, et l’émergence des effets secondaires liés à celui-ci. Un patient de 30 ans ayant un antécédent de varicelle dans l’enfance, a consulté pour une éruption cutanée du flanc droit 10 jours après avoir reçu le vaccin anti- COVID-19 Johnson & Johnson. L’examen cutanée a permis d’objectivé des vésicules confluentes, reposant sur une base érythémateuse siégeant de façon dermatomique sur la région dorso-lombaire droit. Le diagnostic de zona dorso-lombaire droit déclenché par la vaccination anti-COVID 19 a été posé sur la base de l’examen clinique et des examens biologiques revenus normaux.

Keywords

COVID-19 vaccine, herpes zoster, Cameroon

Article Details

How to Cite
Sigha, O. B., Nkoro, G. A. ., Ekambi Kotto, R., Kelbaba, B. B. ., & Kouotou, E. A. . (2022). Herpes Zoster in a Young Cameroonian Triggered by the COVID-19 Vaccine . HEALTH SCIENCES AND DISEASE, 23(7). Retrieved from https://hsd-fmsb.org/index.php/hsd/article/view/3753

References

  1. - Stingeni L, Bianchi L, Zalaudek I, Pigatto PD, Peris K, Patruno C, et al. Adverse cutaneous and mucous reactions from anti SARS-CoV-2 vaccines: recommendations from the Italian Society of Dermatology (SIDeMaST). Ital J Dermatol Venerol. 2021 Apr; 156(2):115-117. doi: 10.23736/S2784-8671.21.06992-3. PMID: 33960747.
  2. - World Health Organization [En ligne]. c2022 [Consulté le 04 /02/2022]. Disponible sur https://www.who.int/countries/cmr/
  3. - Mathieu, E., Ritchie, H., Ortiz-Ospina, E. et al. A global database of COVID-19 vaccinations. Nat Hum Behav (2021)
  4. - Minsante. Covid-19 : la vaccination a commencé[En ligne].c2022 [Consulté le 07/02/2022].disponible sur https://www.minsante.cm/site/?q=fr/content/covid-19-la-vaccination-commenc%C3%A9
  5. - Bogdanov G, Bogdanov I, Kazandjieva J, Tsankov N. Cutaneous adverse effects of the available COVID-19 vaccines. Clin Dermatol. 2021 May-Jun;39(3):523-531. doi: 10.1016/j.clindermatol.2021.04.001. Epub 2021 Apr 27. PMID: 34518015; PMCID: PMC8076732.
  6. - Maranini B, Ciancio G, Cultrera R, Govoni M. Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis. Reumatismo. 2021 Nov 22;73(3). doi: 10.4081/reumatismo.2021.1445. PMID: 34814659.
  7. - Annabi E, Dupin N, Sohier P, Garel B, Franck N, Aractingi S, et al. Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature. J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e847-e850. doi: 10.1111/jdv.17578. Epub 2021 Sep 2. PMID: 34363637; PMCID: PMC8447383.
  8. - Katsikas Triantafyllidis K, Giannos P, Mian IT, Kyrtsonis G, Kechagias KS. Varicella Zoster Virus Reactivation Following COVID-19 Vaccination: A Systematic Review of Case Reports. Vaccines (Basel). 2021 Sep 11;9(9):1013. doi: 10.3390/vaccines9091013. PMID: 34579250; PMCID: PMC8471236.
  9. - Vastarella M, Picone V, Martora F, Fabbrocini G. Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series. J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e845-e846. doi: 10.1111/jdv.17576. Epub 2021 Aug 14. PMID: 34363717; PMCID: PMC8447055. 10.3390/vaccines9091013. PMID: 34579250; PMCID: PMC8471236.(vaccine-z6)
  10. - Cohen JI. Clinical practice: Herpes zoster. N Engl J Med. 2013 Jul 18;369(3):255-63. doi: 10.1056/NEJMcp1302674. PMID: 23863052; PMCID: PMC4789101.
  11. - an Dam CS, Lede I, Schaar J, Al-Dulaimy M, Rösken R, Smits M. Herpes zoster after COVID vaccination. Int J Infect Dis. 2021 Oct;111:169-171. doi: 10.1016/j.ijid.2021.08.048. Epub 2021 Aug 21. PMID: 34428545; PMCID: PMC8379763.

Most read articles by the same author(s)

1 2 > >>